Ramped Up Marketing Efforts and FDA Activity Drive Growth at Top Brand.com
RESTON, Va., Oct. 9 /PRNewswire-FirstCall/ -- comScore, Inc. (Nasdaq: SCOR), a leader in measuring the digital world, today released a study of the top pharmaceutical brand Web sites in Q2 2008. The study revealed that purplepill.com, AstraZeneca's Web site for its heartburn treatment Nexium, generated the most site traffic in Q2 2008 with more than 1 million unique visitors, up 55 percent from year ago. Also showing substantial growth versus last year was diabetes drug Actos, ranking second with 855,000 unique visitors. Insomnia medication Ambien CR, ranked third with 756,000 unique visitors.
"AstraZeneca has aggressively marketed Nexium this year, running
approximately twice as much online display advertising in Q2 as either of
its major competitors, Prevacid and Aciphex," said John Mangano, senior
director, comScore Pharmaceutical Marketing Solutions. "This additional
marketing muscle appears to have helped generate strong site visitation, a
very important marketing step in the competitive pharmaceutical industry."
Top 10 Pharmaceutical Brand Web Sites by Unique Visitors
Q2 2008 vs. Q2 2007
Total U.S. -- Home/Work/University Locations
Source: comScore, Inc.
Unique Visitors (000)
Web Site Q2 2007 Q2 2008 Percent Change
Nexium (purplepill.com) 659 1,021 55 %
Actos (actos.com) 34 855 2399 %
Ambien CR (ambiencr.com) 1,949 756 -61 %
Gardasil (gardasil.com) 912 722 -21 %
Lexapro (lexapro.com) 530 549
|SOURCE comScore, Inc.|
Copyright©2008 PR Newswire.
All rights reserved